Explore our full library of reports covering sector-specific data, observations, and larger trends in life science and healthcare.
HSBC Healthcare Reports
Back to HSBC Innovation BankingAvailable Reports
2024 Annual Venture Healthcare Report
After record investment and aggressive valuations from 2020 through mid 2022, the public market faltered, driving venture firms to re-evaluate their current private portfolio and perform triage for much of 2023. In 2024, investors finally started to invest in new deals. However, based on these near-term trends, investor focus has shifted.
Download the 1H 2024 Report
In 2023, venture healthcare faced a challenging IPO market and limited M&A opportunities,grappling with the valuation and investment froth from 2020-1H 2022. However, 1H 2024 saw increased investment across every sector and numerous new investor-led financings.
Download the 2023 Annual Report
The healthcare market stabilized in 2023. The rate of new investments fell 28%, however, the top 10% of deals still successfully secured substantial funding rounds with step-up valuations. A significant contingent of companies raised new rounds at revised valuations, adhering to the notion that a “flat valuation is the new up-round”.
Download the 1H 2023 Report
In the first half of 2023, as valuations underwent a necessary reset, Venture Capitalists (“VCs”) emerged from their cautious stance and embarked on a fresh wave of investments. These VCs, buoyed by recently raised funds in 2021-2022, assumed the role of leading later-stage rounds, as crossover/hedge funds retreated.
Health 2035 Report
Created in collaboration with Linus and HLTH, this report forecasts the future of health through a comprehensive analysis of the ecosystem. Go in-depth with discussions between visionaries in the ecosystem and studies of young physicians’ predictions for what the state of care will be in the year 2035.
Life Science and Healthcare
Our dedicated team of industry specialists have extensive experience serving life science and healthcare companies.
Join the Email List
Contact Us
*HSBC Innovation Banking is a business division with services provided in the United States by HSBC Bank USA, N.A.
DO NOT include personal/account information in this form. Please contact using the business customer service center phone number to discuss any account questions.
Deposit products offered in the United States by HSBC Bank USA, N.A. Member FDIC.
For clients located outside of the U.S. – Our products and services are not specifically directed at individuals located in the European Union. Our U.S. representatives, as well as our public website, us.hsbc.com, provide products and services governed by U.S. laws and regulations. Our products and services, as well as their specific terms and conditions, are subject to change and may not be available in all territories or to all customers. If you are not located in the U.S., the laws and regulations of your country of residence could affect the offering, negotiation, discussion, provision, and/or use of HSBC U.S. products and services. If you are not a U.S. resident, please read the specific cross-border product and service disclaimers, which are available on the Cross Border Disclosure page of our public website at www.us.hsbc.com/crossborder. Deposit products are offered in the U.S. by HSBC Bank USA, N.A. Member FDIC. Lending products are offered in the U.S. by HSBC Bank USA, N.A. Investments and certain insurance products, including annuities, are offered by HSBC Securities (USA) Inc. (HSI), member NYSE/FINRA/SIPC. Whole life, universal life, term life, and other types of insurance are provided by unaffiliated third parties and offered through HSBC Insurance Agency (USA) Inc., a wholly owned subsidiary of HSBC Bank USA, N.A.
* Limitations apply. International calls cover over 190 countries including Western Europe, Canada, Mexico, China and India.
Need help?
As the leading international bank in the U.S., we connect customers to opportunities and enable them to thrive